Mississippi med spa & injectable regulations
What’s changing for med spas and injectors in Mississippi — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Mississippi. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa? We have not verified Mississippi’s rules against the statute yet, so start with what opening a med spa requires →
Latest Mississippi changes
No new Mississippi changes in the last 6 months. We scan the Mississippi legislature daily and nothing med-spa-relevant has moved since Feb 3, 2026. A quiet state is good news — the record below still applies, and the federal changes further down apply to every Mississippi practice today.
- MONITORLegiScanFeb 3, 2026
MS SB2544: Mississippi Active Pharmaceutical Ingredient Quality Assurance Act; enact to impose certain provisions for compounding.
New regulations could impact drug compounding for med spas.
- CAUTIONLegiScanFeb 13, 2025
MS HB1430: Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.
Potential changes in off-label prescribing regulations in Mississippi.
Federal changes that apply in Mississippi
FDA and Federal Register actions are nationwide — they govern Mississippi practices too.
- CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
- CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
- MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
- CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
- CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
- CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.
What we monitor in Mississippi
- Mississippi legislature — bills on injectables, GLP-1s & scope of practice
- Mississippi Board of Nursing — injector scope & delegation
- Mississippi Medical Board — physician supervision & ownership rules
- Mississippi Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Mississippi med spa compliance — FAQ
- Where do Mississippi med spa and injectable regulations come from?
- Mississippi med spas and injectors are governed by a mix of state and federal authorities — the Mississippi legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Mississippi and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Mississippi?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Mississippi. We track those federal changes alongside any Mississippi-specific rules so you see the full picture for your practice.
- How do I keep up with Mississippi regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Mississippi, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Get Mississippi changes as they publish
We scan the Mississippi legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All states · Regulatory monitoring, not legal advice.